These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2060530)

  • 1. Models for evaluating compounds for activity against Pneumocystis carinii.
    Bartlett MS
    Eur J Clin Microbiol Infect Dis; 1991 Mar; 10(3):199-201. PubMed ID: 2060530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment and prevention of Pneumocystis carinii pneumonia and further elucidation of the P. carinii life cycle with 1,3-beta-glucan synthesis inhibitor L-671,329.
    Schmatz DM; Powles M; McFadden DC; Pittarelli LA; Liberator PA; Anderson JW
    J Protozool; 1991; 38(6):151S-153S. PubMed ID: 1818147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pneumocystis carinii pneumonia therapy with 9-deazainosine in rats.
    Smith JW; Bartlett MS; Queener SF; Durkin MM; Jay MA; Hull MT; Klein RS; Marr JJ
    Diagn Microbiol Infect Dis; 1987 Jun; 7(2):113-8. PubMed ID: 3498606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pneumocystis carinii: improved models to study efficacy of drugs for treatment or prophylaxis of Pneumocystis pneumonia in the rat (Rattus spp.).
    Bartlett MS; Fishman JA; Durkin MM; Queener SF; Smith JW
    Exp Parasitol; 1990 Jan; 70(1):100-6. PubMed ID: 2295322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trophozoite elimination in a rat model of Pneumocystis carinii pneumonia by clinically achievable plasma deferoxamine concentrations.
    Merali S; Chin K; Grady RW; Clarkson AB
    Antimicrob Agents Chemother; 1996 May; 40(5):1298-300. PubMed ID: 8723489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An improved rat model to study efficacy of drugs for treatment or prophylaxis of Pneumocystis carinii pneumonia.
    Barlett MS; Fishman JA; Durkin MM; Queener SF; Smith JW
    J Protozool; 1989; 36(1):77S-78S. PubMed ID: 2785207
    [No Abstract]   [Full Text] [Related]  

  • 7. Activity of terbinafine against Pneumocystis carinii in vitro and its efficacy in the treatment of experimental pneumonia.
    Contini C; Manganaro M; Romani R; Tzantzoglou S; Poggesi I; Vullo V; Delia S; De Simone C
    J Antimicrob Chemother; 1994 Nov; 34(5):727-35. PubMed ID: 7706168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of lipid-soluble inhibitors of dihydrofolate reductase against Pneumocystis carinii in culture and in a rat model of infection.
    Queener SF; Bartlett MS; Jay MA; Durkin MM; Smith JW
    Antimicrob Agents Chemother; 1987 Sep; 31(9):1323-7. PubMed ID: 2445281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Pneumocystis carinii pneumonia with 1,3-beta-glucan synthesis inhibitors.
    Schmatz DM; Romancheck MA; Pittarelli LA; Schwartz RE; Fromtling RA; Nollstadt KH; Vanmiddlesworth FL; Wilson KE; Turner MJ
    Proc Natl Acad Sci U S A; 1990 Aug; 87(15):5950-4. PubMed ID: 2198575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An improved rat model of Pneumocystis carinii pneumonia: induced infections in Pneumocystis-free animals.
    Boylan CJ; Current WL
    J Protozool; 1991; 38(6):138S-140S. PubMed ID: 1818140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Passive immunoprophylaxis with specific monoclonal antibody confers partial protection against Pneumocystis carinii pneumonitis in animal models.
    Gigliotti F; Hughes WT
    J Clin Invest; 1988 Jun; 81(6):1666-8. PubMed ID: 2454947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Furazolidone and nitrofurantoin in the treatment of experimental Pneumocystis carinii pneumonia.
    Walzer PD; Kim CK; Foy J; Zhang JL
    Antimicrob Agents Chemother; 1991 Jan; 35(1):158-63. PubMed ID: 2014971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 8-aminoquinolines effective against Pneumocystis carinii in vitro and in vivo.
    Queener SF; Bartlett MS; Nasr M; Smith JW
    Antimicrob Agents Chemother; 1993 Oct; 37(10):2166-72. PubMed ID: 8257140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of clindamycin with primaquine against Pneumocystis carinii in vitro and in vivo.
    Queener SF; Bartlett MS; Richardson JD; Durkin MM; Jay MA; Smith JW
    Antimicrob Agents Chemother; 1988 Jun; 32(6):807-13. PubMed ID: 3261959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of pentamidine analogues as new agents for the treatment of Pneumocystis carinii pneumonia.
    Tidwell RR; Jones SK; Geratz JD; Ohemeng KA; Bell CA; Berger BJ; Hall JE
    Ann N Y Acad Sci; 1990; 616():421-41. PubMed ID: 2078033
    [No Abstract]   [Full Text] [Related]  

  • 16. Antipneumocystis activity of water-soluble lipopeptide L-693,989 in rats.
    Schmatz DM; Powles MA; McFadden DC; Pittarelli L; Balkovec J; Hammond M; Zambias R; Liberator P; Anderson J
    Antimicrob Agents Chemother; 1992 Sep; 36(9):1964-70. PubMed ID: 1416888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic effect of FK463, a novel antifungal lipopeptide, against Pneumocystis carinii infection in mice.
    Ito M; Nozu R; Kuramochi T; Eguchi N; Suzuki S; Hioki K; Itoh T; Ikeda F
    Antimicrob Agents Chemother; 2000 Sep; 44(9):2259-62. PubMed ID: 10952565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium transport inhibitors decrease proliferation of Pneumocystis carinii in short-term culture.
    Shaw MM; Kleyman TR; Bartlett MS; Smith JW
    J Eukaryot Microbiol; 1994; 41(5):110S. PubMed ID: 7804203
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of histologic and quantitative techniques in evaluation of therapy for experimental Pneumocystis carinii pneumonia.
    Kim CK; Foy JM; Cushion MT; Stanforth D; Linke MJ; Hendrix HL; Walzer PD
    Antimicrob Agents Chemother; 1987 Feb; 31(2):197-201. PubMed ID: 3494426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of intermittent dosage of 8-aminoquinolines for therapy or prophylaxis of Pneumocystis pneumonia in rats.
    Queener SF; Dean RA; Bartlett MS; Milhous WK; Berman JD; Ellis WY; Smith JW
    J Infect Dis; 1992 Apr; 165(4):764-8. PubMed ID: 1532406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.